Mouse lysozyme M is important in pulmonary host defense against Klebsiella pneumoniae infection.
暂无分享,去创建一个
[1] T. Graf,et al. Increased inflammation in lysozyme M-deficient mice in response to Micrococcus luteus and its peptidoglycan. , 2003, Blood.
[2] M. Mikelsaar,et al. Characterization of intestinal lactobacilli as putative probiotic candidates. , 2003, Journal of applied microbiology.
[3] A. Gupta. Hospital-acquired infections in the neonatal intensive care unit--Klebsiella pneumoniae. , 2002, Seminars in perinatology.
[4] A. Pellegrini,et al. A Helix-Loop-Helix Peptide at the Upper Lip of the Active Site Cleft of Lysozyme Confers Potent Antimicrobial Activity with Membrane Permeabilization Action* , 2001, The Journal of Biological Chemistry.
[5] T Matsuzaki,et al. Genetic evidence that antibacterial activity of lysozyme is independent of its catalytic function , 2001, FEBS letters.
[6] K. Tateda,et al. Induction of interleukin-10 and down-regulation of cytokine production by Klebsiella pneumoniae capsule in mice with pulmonary infection. , 2001, Journal of medical microbiology.
[7] R. Epaud,et al. Bacterial Killing Is Enhanced by Expression of Lysozyme in the Lungs of Transgenic Mice1 , 2000, The Journal of Immunology.
[8] T. Graf,et al. Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages , 2000 .
[9] C. Nord,et al. Bifidobacteria and lactobacilli in human health. , 2000, Drugs under experimental and clinical research.
[10] J. Whitsett,et al. Surfactant Protein B (SP-B) −/− Mice Are Rescued by Restoration of SP-B Expression in Alveolar Type II Cells but Not Clara Cells* , 1999, The Journal of Biological Chemistry.
[11] E. Greenberg,et al. Activity of abundant antimicrobials of the human airway. , 1999, American journal of respiratory cell and molecular biology.
[12] Klaus Düring,et al. The non‐enzymatic microbicidal activity of lysozymes , 1999, FEBS letters.
[13] L. Schlegel,et al. Lactobacillus Species as Opportunistic Pathogens in Immunocompromised Patients , 1998, European Journal of Clinical Microbiology and Infectious Diseases.
[14] Wold,et al. The normal Lactobacillus flora of healthy human rectal and oral mucosa , 1998, Journal of applied microbiology.
[15] I. Ofek,et al. SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages. , 1997, The American journal of physiology.
[16] T. Standiford,et al. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. , 1996, Journal of immunology.
[17] T. Standiford,et al. Expression and regulation of chemokines in bacterial pneumonia , 1996, Journal of leukocyte biology.
[18] T. Standiford,et al. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. , 1995, Journal of immunology.
[19] A. Wilson,et al. Recent origin of the P lysozyme gene in mice. , 1990, Nucleic acids research.
[20] R. Mason,et al. Pulmonary lysozyme--a secretory protein of type II pneumocytes in the rat. , 1988, The American review of respiratory disease.
[21] R. Renkawitz,et al. Mouse lysozyme M gene: isolation, characterization, and expression studies. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[22] N. Laible,et al. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides , 1985, Infection and immunity.
[23] S. Spicer,et al. Immunocytochemical localization of lysozymes in respiratory and other tissues. , 1977, Laboratory investigation; a journal of technical methods and pathology.